CMHC 2014 Cardiometabolic Health Congress: Home
Home Home  •  Site Map  •  Search  •  Useful Links
Hypertensionj

Quick Links

CMHC Register Now! CMHC Presentations
Cardiometabolic Health Congress: CME conference on hypertension, dyslipidemia, obesity, cardiovascular risk, atherosclerosis, kidney disease, metabolic syndrome, cardiovascular disease, cardiometabolic risk, cardiovascular diabetes biomarkers, educational meeting, CMHC 2014, CMHC 2015




2013 Program Agenda Wednesday   Thursday   Friday   Saturday
Join our mailing list to receive the latest updates.
Note: Agenda & Faculty are subject to change.
2012 Brochure

Wednesday, October 2, 2013

12:00pm – 1:30pm Lunch Symposium (non-CME)
Consider the Role of the Kidney in Type 2 Diabetes Mellitus

Sponsored by Janssen Pharmaceuticals, Inc.
David S. H. Bell, MB
1:30pm – 2:45pm Afternoon Symposium (non-CME)
A Novel Treatment Option for Chronic Weight Management
Sponsored by Eisai, Inc.
2:45pm – 4:00pm Afternoon Symposium A (non-CME)
The Role of the Kidney in T2DM Pathophysiology
Sponsored by Bristol-Myers Squibb and AstraZeneca LP
2:45pm – 4:00pm Afternoon Symposium B (non-CME)
AZOR® and TRIBENZOR®: Fixed-Dose Combination Therapy
Sponsored by Daiichi Sankyo, Inc.
Robert Busch, MD
4:00pm – 5:15pm Afternoon Symposium
Cardiometabolic Risk in Racial/Ethnic Minorities:
Unique Aspects and Practical Solutions
Sponsored by the American College of Cardiology in collaboration with the National Minority Quality Forum and the Association of Black Cardiologists.
Keith C. Ferdinand, MD
JoAnne Foody, MD
Gary Puckrein, PhD
Laurence Sperling, MD
Tracy Wang, MD
5:15pm – 6:45pm Early Evening Symposium (non-CME)
Advancements in Cardiometabolic Risk Assessment:
Expert Analysis of Recent Evidence and Outcomes
Sponsored by Atherotech Diagnostics Lab
Eliot Brinton, MD
Peter McCullough, MD, MPH
Peter Toth, MD, PhD
7:00pm – 8:30pm Dinner Symposium A (non-CME)
Chronic Management of Obesity:
The Role of a Unique, Once-Daily Treatment
Sponsored by VIVUS, Inc.
W. Timothy Garvey, MD
7:00pm – 8:30pm Dinner Symposium B (non-CME)
KYNAMRO (mipomersen sodium) injection:
An Overview for Clinicians
Sponsored by Genzyme, A SANOFI COMPANY
Sotirios Tsimikas, MD

Thursday, October 3, 2013

6:15am – 7:45am Breakfast Symposium A
State-of-the-Art Antiplatelet Therapy for Patients with ACS: Expert Analysis & Evidence-Based Guidelines for Optimizing Patient Outcomes
Supported by an educational grant from AstraZeneca
Deepak L. Bhatt, MD, MPH
Robert Harrington, MD
E. Magnus Ohman, MD
Marc Sabatine, MD, MPH
6:15am – 7:45am Breakfast Symposium B
New Strategies for Obesity Management & Cardiometabolic Risk Reduction: Expert Perspectives on Novel Therapies Targeting the CNS
Supported by an educational grant from Eisai, Inc.
Louis Aronne, MD
Harold Bays, MD
Lee M. Kaplan, MD, PhD
Steven Smith, MD
8:00am – 8:10am Opening Remarks Christie Ballantyne, MD
8:10am – 8:50am Keynote Session: Inflammation & Cardiometabolic Risk Peter Libby, MD
8:50am – 10:00am Late-Breaking Clinical Trials & FDA Update Moderator: Christie Ballantyne, MD
Presenters & Discussants:
Deepak L. Bhatt, MD, MPH
Robert Eckel, MD
Keith C. Ferdinand, MD
Jay Skyler, MD, MACP
10:00am – 11:00am Morning Break/Exhibit Hall
Sponsored by Takeda Pharmaceuticals U.S.A., Inc.

11:00am – 12:00pm Hot Topics in ACS: Debate Moderator:
Deepak L. Bhatt, MD, MPH
Presenters & Discussants:
Robert Harrington, MD
Daniel Simon, MD
12:15pm – 1:45pm Lunch Symposium A
Triglyceride & Mixed Dyslipidemia Management: Expert Analysis of Cutting-Edge Data & Evidence-Based Recommendations for Reducing Residual CV Risk
Supported by an educational grant from Amarin Pharma, Inc.
Christie Ballantyne, MD
Harold Bays, MD
Deepak L. Bhatt, MD, MPH
Sergio Fazio, MD, PhD
Terry Jacobson, MD
12:15pm – 1:45pm Lunch Symposium B
Alternate Pathways for the Management of Type 2 Diabetes: Expert Analysis on Targeting Dopamine & the CNS for Glycemic Control & CV Risk Reduction
Supported by an educational grant from Santarus, Inc.
David S. H. Bell, MB
Samuel Dagogo-Jack, MD
J. Michael Gaziano, MD, MPH
Jay Skyler, MD, MACP
12:15pm – 1:45pm Lunch Symposium C
Personalized SIHD Management: Evidence-Based Decision Making for Patients at Increased Cardiometabolic Risk
Supported by an independent educational grant from Gilead Sciences, Inc.
JoAnne Foody, MD
Robert Harrington, MD
Mikhail Kosiborod, MD
David Morrow, MD, MPH
2:00pm – 2:45pm Keynote Session: Translating Insights from Human Genetics into Novel Therapies for Dyslipidemia Daniel Rader, MD
2:45pm – 3:30pm Biomarkers vs. Imaging for CV Risk Assessment and Treatment:
Debate
Moderator: Christie Ballantyne, MD
Presenters & Discussant:
Matthew Budoff, MD
Paul Ridker, MD
3:30pm – 4:15pm Afternoon Break/Exhibit Hall  
4:15pm – 5:15pm Clinical Controversies in Lipid Management:
Case-Based Presentations & Discussion
Moderator: Christie Ballantyne, MD
Presenters:
Harold Bays, MD
Robert Eckel, MD
JoAnne Foody, MD
5:15pm Closing Remarks Christie Ballantyne, MD
5:30pm – 6:30pm Welcome Reception  
7:00pm – 9:00pm Dinner Symposium A
The Next-Generation of Weight-Loss Medications:
Expert Recommendations for Managing Obesity,
Diabetes & Cardiometabolic Risk
Supported by an educational grant from VIVUS, Inc.
Robert Eckel, MD
W. Timothy Garvey, MD
Samuel Klein, MD
Robert Kushner, MD
Arya Sharma, MD, PhD
7:00pm – 9:00pm Dinner Symposium B
Personalized T2DM Management: The Role of Incretin Therapies Along the Continuum of Care
This activity is supported by an independent medical education grant from Bristol-Myers Squibb and AstraZeneca, LP
Robert Chilton, DO
Richard Pratley, MD
Benjamin Scirica, MD
Carol Wysham, MD

Friday, October 4, 2013

6:15am – 7:45am Breakfast Symposium A
Next-Generation Vasodilating Beta Blockers Along the HTN Continuum of Care: Expert Recommendations for Targeting Endothelial Dysfunction, BP, and Cardiometabolic Risk
Supported by an educational grant from
Forest Laboratories, Inc.
George Bakris, MD
Keith C. Ferdinand, MD
Thomas Giles, MD
Michael Weber, MD
6:15am – 7:45am Breakfast Symposium B
State-of-the-Art Management of Severe and Familial Hypercholesterolemia: Examining the Role of Antisense Therapy in Clinical Practice
Supported by an educational grant from
Genzyme, A SANOFI COMPANY
P. Barton Duell, MD
Peter Jones, MD
Patrick Moriarty, MD
Evan Stein, MD, PhD
8:00am – 8:10am Opening Remarks Jay Skyler, MD, MACP

8:10am – 8:40am Personalized Diabetes Management: Selecting the Right Therapy John Buse, MD, PhD
8:40am – 9:10am Insulin Therapy: The State-of-the-Science Irl Hirsch, MD 
9:10am – 9:50am T1DM 2013: Translating the Latest Advances into Clinical Practice Robert Eckel, MD
Jay Skyler, MD, MACP
9:50am – 10:50am Morning Break/Exhibit Hall  
10:50am – 11:30am Pediatric Obesity & T2DM Moderator: Jay Skyler, MD, MACP
Presenters:
Sonia Caprio, MD
David Ludwig, MD
11:30am – 12:15pm Diabetes Panel Discussion & Audience Q&A Moderator: Jay Skyler, MD, MACP
Discussants: John Buse, MD
Sonia Caprio, MD
Robert Eckel, MD
Irl Hirsch, MD
David Ludwig, MD
12:30pm – 2:00pm Lunch Symposium A
Advances in Basal Insulin Therapy: Expert Analysis of Novel Formulations, Combination Therapies & Delivery Technologies
Supported by an educational grant from Novo Nordisk, Inc.
John Buse, MD, PhD
Irl Hirsch, MD
Luigi Meneghini, MD
Bernard Zinman, MD
12:30pm – 2:00pm Lunch Symposium B
Getting to the Heart of Diabetic Dyslipidemia in High-Risk Patients: Clinical Dilemmas & Novel Approaches to Cardiovascular Risk Reduction
Supported by an educational grant from Genentech, A Member of the Roche Group
Darren McGuire, MD
Sunder Mudaliar, MD
Jorge Plutzky, MD
Jean-Claude Tardif, MD
2:15pm – 2:45pm Elevated Serum Creatinine: Different Meaning in Different Settings? George Bakris, MD 
2:45pm – 3:15pm CKD Endpoints in Clinical Trials: Guidance for Clinical Practice Glenn Chertow, MD
3:15pm – 4:00pm Afternoon Break/Exhibit Hall  
4:00pm – 4:30pm Alternative Therapies for HTN: Examining the Evidence
Robert Brook, MD
4:30pm - 5:30pm Clinical Controversies in HTN Management:
Expert Perspectives & Discussion
Moderator: George Bakris, MD
Case Presenters & Discussants:
Rajiv Agarwal, MD
Raymond Townsend, MD
William White, MD
5:30pm Closing Remarks George Bakris, MD
6:30pm - 8:30pm Dinner Symposium A
Obesity Management 2013: Expert Perspectives on the Clinical Impact of Novel & Emerging Therapies
Supported by an educational grant from Novo Nordisk, Inc
Caroline Apovian, MD
Robert Eckel, MD
Ken Fujioka, MD
Robert Kushner, MD
6:30pm - 8:30pm Dinner Symposium B
CV Outcomes for Oral & Incretin-Based Therapies: Examining Cutting-Edge Data & Clinical Implications for Patient Care
This activity is supported by an educational grant from
Takeda Pharmaceuticals International, Inc., US Region
George Bakris, MD
William Cushman, MD
Vivian Fonseca, MD
William White, MD

Saturday, October 5, 2013

6:15am – 7:45am Breakfast Symposium
State-of-the-Art Advances in T2DM Management: Expert Analysis of New & Emerging GLP-1 Receptor Agonists
Supported by an educational grant from Lilly USA, LLC
Thomas Blevins, MD
Anne Peters, MD
Carol Wysham, MD
8:00am – 8:10am Opening Remarks Robert Eckel, MD
8:10am – 9:00am Keynote Session
Brown Fat: Is It Important to Body Weight and Metabolic Risk in Humans?
C. Ronald Kahn, MD
9:00am – 9:30am Metabolic Surgery 2013: Patient Selection and Outcomes Francesco Rubino, MD
9:30am – 10:00am Look AHEAD: Interpreting the Results for Clinical Practice David Nathan, MD
10:00am – 10:15am Morning Break  
10:15am – 11:00am Diet & Exercise: What's the Optimal Prescription? Moderator: Robert Eckel, MD
Presenters and Discussants:
I-Min Lee, MD, ScD
Barbara Millen, DPH, RD, RADA
11:00am – 11:30am Clinical Management of Obesity-Related NAFLD Samuel Klein, MD
11:30am – 11:50am Obesity Medicine: Practical Pointers for Your Office or Clinic Robert Kushner, MD
11:50am – 12:30pm Clinical Challenges & Practical Strategies for Obesity Management
  • Where does obesity pharmacotherapy or surgery fit into the treatment algorithm for diabetes?
  • When is it more important to treat the comorbidity vs. focus on weight loss?
  • How much weight loss do you need to achieve to tackle comorbidities?
  • Moderator: Robert Eckel, MD
    Discussants:
    C. Ronald Kahn, MD
    Samuel Klein, MD
    Robert Kushner, MD
    I-Min Lee, MD, ScD
    Barbara Millen, DPH, RD, RADA
    David Nathan, MD
    Francesco Rubino, MD
    12:30pm Closing Remarks Robert Eckel, MD
     
     
    MMS ACCF FH Foundation ASH ISHIB ACPM ASH APAC